1st Quarter - Report — COHERUS BIOSCIENCES for COHERUS BIOSCIENCES, INC. (2026)

Firm

COHERUS BIOSCIENCES

Client

COHERUS BIOSCIENCES, INC.

Income

—

Expenses

$80,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production

Lobbyist	Covered position, as disclosed
DAVID SANDERS	Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; White House Office; Office of Management & Budget (OMB); Export-Import Bank of the United States (EXIM Bank); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Executive Office of the President (EOP); Office of Science & Technology Policy (OSTP)

Government Issues GOV

Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.

Lobbyist	Covered position, as disclosed
DAVID SANDERS	—

Contacted: Defense Advanced Research Projects Agency (DARPA); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); White House Office; Federal Emergency Management Agency (FEMA); President of the U.S.; Vice President of the U.S.; Defense Nuclear Facilities Safety Board; Executive Office of the President (EOP); SENATE; Natl Security Council (NSC); Office of Management & Budget (OMB); Energy, Dept of; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.